Artificial intelligence in inflammatory bowel disease
Inflammatory bowel disease (IBD) is a complex condition influenced by various intestinal factors. Advances in next-generation sequencing, high-throughput omics, and molecular network technologies have significantly accelerated research in this field. The emergence of artificial intelligence (AI) has further enhanced the efficient utilization and interpretation of datasets, enabling the discovery of clinically actionable insights. AI is now extensively applied in gastroenterology, where it aids in endoscopic analyses, including the diagnosis of colorectal cancer, precancerous polyps, gastrointestinal inflammatory lesions, and bleeding. Additionally, AI supports clinicians in patient stratification, predicting disease progression and treatment responses, and adjusting treatment plans in a timely manner. This approach not only reduces healthcare costs but also improves patient health and safety. This review outlines the principles of AI, the current research landscape, and future directions for its applications in IBD, with the goal of advancing targeted treatment strategies.
No keywords indexed for this article. Browse by subject →
Yasuharu Maeda, Shin-Ei Kudo, Noriyuki Ogata et al.
Eric J. Topol
Alison R. Erickson, Brandi L. Cantarel, Regina Lamendella et al.
Xuehua Li, Dong Liang, Jixin Meng et al.
Dan Turner, Amanda Ricciuto, Ayanna Lewis et al.
Simon P L Travis, Dan Schnell, Piotr Krzeski et al.
Xianyong Gui, Alina Bazarova, Rocío Del Amor et al.
Dawid Rymarczyk, Weiwei Schultz, Adriana Borowa et al.
Showing 50 of 77 references
Horia Minea, Ana-Maria Singeap · 2025
- Published
- Apr 25, 2025
- Vol/Issue
- 31(4)
- Pages
- 197-205
- License
- View
You May Also Like
Jin Huang, Wen-Na Liu · 2020
157 citations
Jaudah Al-Maghrabi, Eman Emam · 2018
24 citations
Ujjwal Gorsi, Anmol Bhatia · 2014
20 citations
Neha R. Santucci, Sarah Kemme · 2022
11 citations